Azathioprine: effects on neuromuscular transmission.
The neuromuscular effects of azathioprine were examined in the in-vivo cat soleus muscle preparation. In concentrations ranging from 10 to 1,000 mug/kg, administered intra-arterially, the agent caused motor axons to fire repetitively and produced a dose-related increase in the force of contraction. The drug reversed neuromuscular blockage produced by d-tubocurarine and potentiated the neuromuscular blockade produced by succinylcholine. The effects of theophylline, a phosphodiesterase inhibitor, on neuromuscular transmission were identical to those produced by azathioprine. Using an in-vitro assay preparation, azathioprine was found to produce 50 per cent inhibition (IC50) of phosphodiesterase at a concentration of 2 X 10(-5) M. In the same preparation, theophylline had an IC50 of 1 X 10(-4) M. Neither agent in concentrations to 10(-2) M affected cholinesterase activity measured in vitro. It is concluded that the effects of azathioprine on neuromuscular transmission are due to inhibition of phosphodiesterase in the motor nerve terminal.
D000818:Animals; D001379:Azathioprine / Q000008:administration & dosage / Q000494:pharmacology*; D002415:Cats; D002417:Cattle; D000242:Cyclic AMP / Q000378:metabolism; D009119:Muscle Contraction / Q000187:drug effects; D009121:Muscle Denervation; D009469:Neuromuscular Junction / Q000187:drug effects / Q000502:physiology*; D010726:Phosphodiesterase Inhibitors; D013390:Succinylcholine / Q000494:pharmacology; D009435:Synaptic Transmission / Q000187:drug effects*; D013806:Theophylline / Q000494:pharmacology; D014403:Tubocurarine / Q000494:pharmacology
D010726:Phosphodiesterase Inhibitors; D013806:Theophylline; D000242:Cyclic AMP; D013390:Succinylcholine; D001379:Azathioprine; D014403:Tubocurarine